RecruitingNot ApplicableNCT05416567

Embolization for Meningioma

Therapeutic Endovascular Embolization for Intracranial Meningioma

Sponsor

St. Olavs Hospital

Enrollment

30 participants

Start Date

Oct 10, 2022

Study Type

INTERVENTIONAL

Conditions

Meningioma

Summary

The natural course for meningioma suggests that a majority will grow over time. Treatment is usually indicated in growing or symptomatic meningiomas. Surgery is usually primary treatment, but there is a significant risk of adverse effects. Stereotactic radiotherapy is most often reserved to treat relapses after surgery, and except for surgery and radiotherapy there are no other established treatment methods. Endovascular embolization may be used in selected cases as a preoperative adjunct to reduce intraoperative bleeding. There is a need for more treatment options in patients with meningioma, both in uncomplicated, asymptomatic cases and in more complex cases. The aim of this study is to assess radiological and clinical results of therapeutic endovascular embolization for meningioma

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a less invasive procedure called embolization as a way to treat meningiomas (typically benign brain tumors) before or instead of surgery. Embolization involves blocking the blood vessels that feed the tumor, which can shrink it or reduce surgical risk. **You may be eligible if...** - You are 18 or older - You have a meningioma diagnosed by imaging (typically a brain MRI) - Your doctor has recommended treatment because the tumor is growing or causing symptoms - The tumor's blood supply appears to come through a specific artery (middle meningeal artery) **You may NOT be eligible if...** - You are unable to give informed consent - You have a medical condition that makes the procedure unsafe - You are allergic to contrast dye used in imaging procedures - You are pregnant - Your tumor is not suitable for this approach based on its location or blood supply Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.